Keywords: bayer, 3rd-qtr, income, down, schering, ag, buy
Bayer's 3rd-qtr income down 35% on Schering AG buy, while sales climb 26%
Article | 04 December 2006
German drugmaker Bayer says that, for the third quarter of 2006, its net income was 320.0 million euros ($419.0 million), down 35% from the 493.0 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
